CN108402320A - A kind of composite probiotics preparations and its application in pig starter feed - Google Patents
A kind of composite probiotics preparations and its application in pig starter feed Download PDFInfo
- Publication number
- CN108402320A CN108402320A CN201810186361.8A CN201810186361A CN108402320A CN 108402320 A CN108402320 A CN 108402320A CN 201810186361 A CN201810186361 A CN 201810186361A CN 108402320 A CN108402320 A CN 108402320A
- Authority
- CN
- China
- Prior art keywords
- parts
- cfu
- composite probiotics
- probiotics preparations
- streptococcus thermophilus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 139
- 239000006041 probiotic Substances 0.000 title claims abstract description 94
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 94
- 239000002131 composite material Substances 0.000 title claims abstract description 70
- 239000007858 starting material Substances 0.000 title claims description 15
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 46
- 241001465754 Metazoa Species 0.000 claims abstract description 46
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 45
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 42
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 41
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 40
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 40
- 241000194108 Bacillus licheniformis Species 0.000 claims abstract description 39
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims abstract description 39
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 38
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 33
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 33
- 229940050168 zinc lactate Drugs 0.000 claims abstract description 33
- 239000011576 zinc lactate Substances 0.000 claims abstract description 33
- 235000000193 zinc lactate Nutrition 0.000 claims abstract description 33
- 229920000926 Galactomannan Polymers 0.000 claims abstract description 23
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims description 59
- 241000894006 Bacteria Species 0.000 claims description 54
- 239000000203 mixture Substances 0.000 claims description 18
- 229920001542 oligosaccharide Polymers 0.000 claims description 18
- 239000002552 dosage form Substances 0.000 claims description 8
- 241000726221 Gemma Species 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 241001037822 Bacillus bacterium Species 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 1
- 229960003487 xylose Drugs 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 29
- 102000004889 Interleukin-6 Human genes 0.000 abstract description 9
- 108090001005 Interleukin-6 Proteins 0.000 abstract description 9
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract description 9
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract description 9
- 229940100601 interleukin-6 Drugs 0.000 abstract description 9
- 241001591005 Siga Species 0.000 abstract description 7
- 230000000968 intestinal effect Effects 0.000 abstract description 7
- 210000004347 intestinal mucosa Anatomy 0.000 abstract description 7
- 208000035240 Disease Resistance Diseases 0.000 abstract description 5
- 102000003777 Interleukin-1 beta Human genes 0.000 abstract description 5
- 108090000193 Interleukin-1 beta Proteins 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 abstract 1
- 102100040247 Tumor necrosis factor Human genes 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 22
- 238000000034 method Methods 0.000 description 17
- 238000012360 testing method Methods 0.000 description 15
- 241000193830 Bacillus <bacterium> Species 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 150000002482 oligosaccharides Chemical class 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 244000063299 Bacillus subtilis Species 0.000 description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 108010059892 Cellulase Proteins 0.000 description 4
- 241000194032 Enterococcus faecalis Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 229940106157 cellulase Drugs 0.000 description 4
- 229940032049 enterococcus faecalis Drugs 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 102000000589 Interleukin-1 Human genes 0.000 description 3
- 108010002352 Interleukin-1 Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- 150000004823 xylans Chemical class 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102100032487 Beta-mannosidase Human genes 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 108010055059 beta-Mannosidase Proteins 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- TWNIBLMWSKIRAT-RWOPYEJCSA-N (1r,2s,3s,4s,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](O)[C@@H]2O TWNIBLMWSKIRAT-RWOPYEJCSA-N 0.000 description 1
- -1 250-300 parts Proteins 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 101100503585 Mus musculus Furin gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
Abstract
A kind of composite probiotics preparations, which is characterized in that the composite probiotics preparations are made of bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate.The composite probiotics preparations of the present invention can effectively improve the growing state of piglet, it improves Average weight increasing a day, reduce diarrhea rate, interleukin-1 beta (1 β of IL), interleukin-6 (IL 6) and tumor necrosis factor α (TNF α), the intestinal mucosa SIgA that can also be improved simultaneously in piglet body are horizontal, improve the disease resistance of piglet, moreover it is possible to piglet be helped to establish the intestinal flora environment of health.And production cost is low, utilization easy to spread, has wide utilization foreground.
Description
Technical field：
The invention belongs to biotechnologies and field of fodder, and in particular to a kind of composite probiotics preparations and its in piglet
Application in feed.
Background technology：
During modern large scale of pig farm, weaned piglet is an important link in growth course, due to early weaning,
What weanling piglet faced first is exactly the change of environment and feed, inevitably results from a series of psychology, environment, battalion
The stress reaction of support etc., and intestine of young pigs immune system could generally be reached maturity in 4~7 week old substantially, therefore it is early
Piglet itself generates immune antiboidy level when phase weans and cell immunocompetent is relatively low, along with having interrupted maternal immunity antibody
It providing, the immunity function for keeping piglet not perfect is further weakened by that stress be influenced, and piglet body circulation antibody level reduces,
Inhibit cell immunocompetent, show significant immunosupress, so as to cause intestine of young pigs flora imbalance, feed intake declines, disappears
Change bad, disease-resistant force difference, slow-growing, diarrhea is even dead, these problems annoying the development of intensive industrialized piggery always.Base
In the presence of problem above, antibiotic largely uses in weanling pig daily ration, as the drug resistance that abuse of antibiotics is brought is asked
Topic and problem of environmental pollution are paid more and more attention, and feeding antibiotic, which is used for a long time, can make pathogenic bacteria generate drug resistance and pass through food
Chain threatens human health and safety belt, therefore it is already that aquaculture is badly in need of solving to find environmentally protective Substitutes For Antibiotic
One of the problem of.
Probiotics is also known as raw element of probiotic, active bacteria formulation, profit etc., is proposed by Parker, it is a kind of dynamic by adjusting
Object gastrointestinol microorganism colony balance is to realize the micro- life of activity for preventing disease, improving feed digestibility and promoting growth of animal
The general designation of object, culture and other products.Probiotics is flat by adjusting Tiny ecosystem as a kind of new green environment protection additive
Weighing apparatus and desirable influence is generated to animal, can Direct-fed or with Basic drawing mixed feeding, no drug resistance, noresidue, without pair
It acts on, is safe and reliable, free from environmental pollution, developing and utilize and paid attention to by various countries.Probiotic products are rationally utilized, can be improved
The growth performance and immune level of animal, can effectively prevent and treat grice diarrhoea, reduce stress generation, be conducive to son
The growth of pig.Probiotics effectively can adjust and maintain the colony balance of enteron aisle, improve livestock and poultry cultivation environment, improve feed conversion
Rate improves the barrier function of animal and bird intestines, enhances the immunity of body, is generally acknowledged one of optimum antibiotic substitute.
In recent years about the addition of probiotics in feed to weanling pig growth and development, intestinal flora, immune function and
The research of diarrhea situation etc. is more.The study found that probiotics is applied in pig production, weaning pigs weight can be significantly reduced
Than reducing Stomach duodenum pH value, improving liver index, adjust weanling pig intestinal health.Occupation rate is higher on Vehicles Collected from Market
Probiotic products are mainly bacillus subtilis mushroom, lactic acid bacteria class and budding fungus.It is reported that lactic acid bacteria can improve chitling road
Tiny ecosystem and health status improve the growth performance of suckling pig；Yeast Propagation increases into the mechanism that fiber feedstuff is degraded with it
Rumen Fungi quantity is related with cellulase activity；After bacillus subtilis enters animal intestinal tract, enteron aisle aerogenesis pod can significantly reduce
Film clostridium, escherichia coli and detection of Salmonella quantity, and to the development of intestinal villi have significant facilitation.
CN201310633814.4 provides a kind of piglet composite probiotics preparations product and method, should in terms of mass parts
Composite probiotics preparations contain 40-80 parts of yeast, 80-110 parts of enterococcus faecalis, 400-520 parts of bacillus subtilis, zytase
150-180 parts, 5-12 parts of mannase, 30-70 parts of cellulase, 0-120 parts of 10-40 parts of protease and amylase 8；More
Preferably, said preparation includes 66 parts of yeast, 98 parts of enterococcus faecalis, 492 parts of bacillus subtilis, 165 parts of zytase, sweet dew
96 parts of 9 parts of dextranase, 49 parts of cellulase, 25 parts of protease and amylase.The composite probiotics preparations are added to child care pig
Piglet is fed in daily ration, can enhance piglet immunity of organisms, reduces diarrhea, promotes piglet growth, improves piglet weightening.
CN201210391466.X provides boar composite probiotics preparations and preparation method thereof, component and weight
Part is as follows：Lactobacillus rhamnosus preparation 20-30, enterococcus faecalis preparation 15-25, lactic acid bacillus preparation 8-18, wax-like gemma
Bacillus preparation 7-17, bacillus subtilis formulation 10-20, brewer's yeast preparation 10-20；Each component prepares bacterial strain uses therefor
Lactobacillus rhamnosus LT22, enterococcus faecalis CH13, bacillus SC27, Bacillus cercus SL1, bacillus subtilis and beer
Yeast；The techniques such as the activated culture of each component, expansion culture, freeze-drying and wheat bran absorption are made, and mix in proportion i.e.
Pig composite probiotics preparations are obtained, liquid dosage form and solid dosage forms are divided into.Said preparation contains more probiotics of high activity, thalline
Cell resistance power is strong, metabolite is abundant, nutritious to pig, immune and prebiotic effect, especially to pregnant sow and weanling pig
Using effect is good.
CN201310739737.0 discloses a kind of suckling piglet specific enzyme and preparation method thereof containing profitable probliotics, described to contain
The suckling piglet specific enzyme of profitable probliotics is grouped as by the group of following parts by weight：5-20 parts of Chinese herbal medicine powder, zytase 800-
1200 parts, 80-120 parts of cellulase, 250-300 parts, mannase 15-25 of bacillus licheniformis culture, protease
600-1000,50-80 parts of mesophilicα-diastase.Preparation method is as follows：After bacillus licheniformis is fermented by filtering, concentration,
The dry culture obtained is compounded with other compositions, and gained complex enzyme can improve food conversion ratio, and reduces feed cost, is improved and is protected
Deposit stability.
However, either the mixed fermentation product of single culture tunning or several probiotics, either preparation are straight
It connects and gavages or mixed with its Basic drawing, performance results are also unstable, this mainly (adds with the type of probiotics, viable bacteria concentration
Add ratio), to feed mode related with pig age in days.
Invention content：
The problem of developing for current composite probiotics preparations cultivates in conjunction with pig, is especially deposited in piglet cultivation
Weaning stress caused by intestinal bacilli illness, feed intake decline, indigestion, disease-resistant force difference is slow-growing, and diarrhea is even
The technical problems such as death, the present invention is intended to provide a kind of composite probiotics preparations and its application in pig starter feed.
In order to solve the above technical problems, present invention employs following technological means：
A kind of composite probiotics preparations, which is characterized in that the composite probiotics preparations are by bacillus licheniformis, wine brewing ferment
Mother, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate group
At.
Preferably, the composite probiotics preparations by following weight point at being grouped as：10-15 parts of bacillus licheniformis,
2-4 parts of saccharomyces cerevisiaes, 20-30 parts of animal bifidobacterias, 20-30 parts of lactobacillus acidophilus, 3-5 parts of streptococcus thermophilus, 0.0004-
0.0006 part of tryptophan, 20-30 parts of xylo-oligosaccharides, 2-3 portions of galactomannans and 0.00003-0.00008 parts of zinc lactate groups
At.
Preferably, the composite probiotics preparations by following weight point at being grouped as：12 parts of bacillus licheniformis, 3 parts
Saccharomyces cerevisiae, 25 parts of animal bifidobacterias, 25 parts of lactobacillus acidophilus, 4 parts of streptococcus thermophilus, 0.0005 part of tryptophan, 25 parts it is low
Xylan, 2.5 portions of galactomannans and 0.00005 part of zinc lactate composition.
Preferably, the composite probiotics preparations by following weight point at being grouped as：10 parts of bacillus licheniformis, 2 parts
Saccharomyces cerevisiae, 30 parts of animal bifidobacterias, 20 parts of lactobacillus acidophilus, 3 parts of streptococcus thermophilus, 0.0004 part of tryptophan, 20 parts it is low
Xylan, 2 portions of galactomannans and 0.00008 part of zinc lactate composition.
Preferably, the composite probiotics preparations by following weight point at being grouped as：15 parts of bacillus licheniformis, 3 parts
Saccharomyces cerevisiae, 20 parts of animal bifidobacterias, 30 parts of lactobacillus acidophilus, 5 parts of streptococcus thermophilus, 0.0006 part of tryptophan, 30 parts it is low
Xylan, 3 portions of galactomannans and 0.00003 part of zinc lactate composition.
Preferably, wherein bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus are equal
For bacterium powder dosage form, effectively viable bacteria content is 1.0 × 10 in Bacillus licheniformis powder preparation8CFU/g-2.0×108CFU/
G, effectively viable bacteria content is 1.5 × 10 in S. cervisiae powder preparation8CFU/g-2.0×108CFU/g, animal bifidobacteria bacterium powder
Effective viable bacteria content is 1.0 × 10 in preparation9CFU/g-2.0×109CFU/g, effectively viable bacteria contains in lactobacillus acidophilus bacterium powder preparation
Amount is 5.0 × 108CFU/g-8.0×108CFU/g, effectively viable bacteria content is 3.0 × 10 in streptococcus thermophilus bacterium powder preparation7CFU/
g-5.0×107CFU/g。
Preferably, wherein bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus are equal
For bacterium powder dosage form, effectively viable bacteria content is 1.5 × 10 in Bacillus licheniformis powder preparation8CFU/g, saccharomyces cerevisiae bacterium powder
Effective viable bacteria content is 1.75 × 10 in preparation8CFU/g, in animal bifidobacteria bacterium powder preparation effectively viable bacteria content be 1.5 ×
109CFU/g, effectively viable bacteria content is 6.5 × 10 in lactobacillus acidophilus bacterium powder preparation8CFU/g, in streptococcus thermophilus bacterium powder preparation
Effective viable bacteria content is 4.0 × 107CFU/g。
The preparation method of the composite probiotics preparations is also claimed in the present invention, which is characterized in that the preparation method
Include the following steps：Step 1 weighs bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus by weight
With streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate；Step 2, the lichens bud that will be weighed
Spore bacillus, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus and streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, gala
Mannosan and zinc lactate are uniformly mixed, and are then dispensed, are placed at 4 DEG C and preserve.
Application of the composite probiotics preparations in pig starter feed is also claimed in the present invention, which is characterized in that described
Additive amount of the composite probiotics preparations in pig starter feed is 0.2-0.4% (mass percent).
A kind of pig starter feed is also claimed in the present invention, which is characterized in that 0.2-0.4% is added in the pig starter feed
The composite probiotics preparations of mass percentage.
A kind of method for breeding of piglet is also claimed in the present invention, which is characterized in that using added with 0.2-0.4% mass
The pig starter feed of the composite probiotics preparations of percentage composition is fed.
Based on above technical scheme, the invention has the advantages that and advantageous effect：
First, immunity of organisms is low, intestines according to the physiology and growth characteristic of piglet, especially after weaning stress by the present invention
The characteristics of road normal flora is not yet established uses bacillus licheniformis, saccharomyces cerevisiae, moves in conjunction with the nutritional need of probiotics
It is prepared by object Bifidobacterium, lactobacillus acidophilus, streptococcus thermophilus, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate combination
The composite probiotics preparations of the present invention are obtained, which can effectively improve the growing state of piglet, carry
High Average weight increasing a day reduces diarrhea rate, while can also improve the interleukin-1 ' beta ' in piglet body (IL-1 β), interleukin-6
(IL-6) and tumor necrosis factor-alpha (TNF-α), intestinal mucosa SIgA are horizontal, improve the disease resistance of piglet, moreover it is possible to help young
Pig establishes the intestinal flora environment of health.
Second, by experiments have shown that, the present invention it is Promethean use tryptophan, xylo-oligosaccharide, galactomannans and
The mode of zinc lactate combination can effectively improve the using effect of probiotics preparation, and experiment comparison result is it is found that simple addition
Tryptophan or zinc lactate cannot obtain good technique effect, only when the two is added simultaneously in use, could obtain good
Technique effect, diarrhea rate falls to the 1/5 of control group 1-3, and Average weight increasing a day improves 10g/d or more, illustrate tryptophan and
Zinc lactate has the function of synergy in composite probiotics preparations.The ratio and tryptophan of oligosaccharide, zinc lactate add
Add and has great importance for the present invention, the restriction of exactly this oligosaccharide adding proportion and tryptophan, zinc lactate
Addition achieves unexpected technique effect to the raising of piglet immunological ability.The ratio and tryptophan of oligosaccharide, lactic acid
The addition of zinc has great importance for the present invention, the restriction of exactly this oligosaccharide adding proportion and tryptophan, breast
The addition of sour zinc achieves unexpected technique effect to the raising of piglet immunological ability.
In conclusion the composite probiotics preparations of the present invention can effectively improve the growing state of piglet, improve average daily
Weightening reduces diarrhea rate, while can also improve the interleukin-1 ' beta ' in piglet body (IL-1 β), interleukin-6 (IL-6)
It is horizontal with tumor necrosis factor-alpha (TNF-α), intestinal mucosa SIgA, improve the disease resistance of piglet, moreover it is possible to piglet be helped to establish
The intestinal flora environment of health.And production cost is low, utilization easy to spread, has wide utilization foreground.
Specific implementation mode：
Embodiment 1：A kind of composite probiotics preparations, the composite probiotics preparations are by following weight point at being grouped as：
12 parts of bacillus licheniformis, 3 parts of saccharomyces cerevisiaes, 25 parts of animal bifidobacterias, 25 parts of lactobacillus acidophilus, 4 parts of streptococcus thermophilus,
0.0005 part of tryptophan, 25 parts of xylo-oligosaccharides, 2.5 portions of galactomannans and 0.00005 part of zinc lactate composition.
Wherein bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus are bacterium powder
Dosage form, effectively viable bacteria content is 1.5 × 10 in Bacillus licheniformis powder preparation8CFU/g, in S. cervisiae powder preparation
Effective viable bacteria content is 1.75 × 108CFU/g, effectively viable bacteria content is 1.5 × 10 in animal bifidobacteria bacterium powder preparation9CFU/
G, effectively viable bacteria content is 6.5 × 10 in lactobacillus acidophilus bacterium powder preparation8CFU/g is effectively living in streptococcus thermophilus bacterium powder preparation
Bacterial content is 4.0 × 107CFU/g。
The preparation method of the composite probiotics preparations includes the following steps：Step 1 weighs lichens gemma by weight
Bacillus, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus and streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, gala are sweet
Reveal glycan and zinc lactate；Step 2, by the bacillus licheniformis weighed, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus
With streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate be uniformly mixed, then packing,
It is placed at 4 DEG C and preserves.
Embodiment 2：A kind of composite probiotics preparations, the composite probiotics preparations are by following weight point at being grouped as：
10 parts of bacillus licheniformis, 2 parts of saccharomyces cerevisiaes, 30 parts of animal bifidobacterias, 20 parts of lactobacillus acidophilus, 3 parts of streptococcus thermophilus,
0.0004 part of tryptophan, 20 parts of xylo-oligosaccharides, 2 portions of galactomannans and 0.00008 part of zinc lactate composition.
Wherein bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus are bacterium powder
Dosage form, effectively viable bacteria content is 2.0 × 10 in Bacillus licheniformis powder preparation8CFU/g, in S. cervisiae powder preparation
Effective viable bacteria content is 2.0 × 108CFU/g, effectively viable bacteria content is 2.0 × 10 in animal bifidobacteria bacterium powder preparation9CFU/g,
Effective viable bacteria content is 8.0 × 10 in lactobacillus acidophilus bacterium powder preparation8CFU/g, effective viable bacteria in streptococcus thermophilus bacterium powder preparation
Content is 5.0 × 107CFU/g。
The preparation method of the composite probiotics preparations includes the following steps：Step 1 weighs lichens gemma by weight
Bacillus, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus and streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, gala are sweet
Reveal glycan and zinc lactate；Step 2, by the bacillus licheniformis weighed, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus
With streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate be uniformly mixed, then packing,
It is placed at 4 DEG C and preserves.
Embodiment 3：A kind of composite probiotics preparations, the composite probiotics preparations are by following weight point at being grouped as：
15 parts of bacillus licheniformis, 3 parts of saccharomyces cerevisiaes, 20 parts of animal bifidobacterias, 30 parts of lactobacillus acidophilus, 5 parts of streptococcus thermophilus,
0.0006 part of tryptophan, 30 parts of xylo-oligosaccharides, 3 portions of galactomannans and 0.00003 part of zinc lactate composition.
Wherein bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus are bacterium powder
Dosage form, effectively viable bacteria content is 1.0 × 10 in Bacillus licheniformis powder preparation8CFU/g, in S. cervisiae powder preparation
Effective viable bacteria content is 1.5 × 108CFU/g, effectively viable bacteria content is 1.0 × 10 in animal bifidobacteria bacterium powder preparation9CFU/g,
Effective viable bacteria content is 5.0 × 10 in lactobacillus acidophilus bacterium powder preparation8CFU/g, effective viable bacteria in streptococcus thermophilus bacterium powder preparation
Content is 3.0 × 107CFU/g。
The preparation method of the composite probiotics preparations includes the following steps：Step 1 weighs lichens gemma by weight
Bacillus, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus and streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, gala are sweet
Reveal glycan and zinc lactate；Step 2, by the bacillus licheniformis weighed, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus
With streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate be uniformly mixed, then packing,
It is placed at 4 DEG C and preserves.
Embodiment 4：Safety testing
(1) acute toxicity test in mice：Mix is carried out using the composite probiotics preparations and feed of the embodiment of the present invention 1
(mass ratio 0.08:1, i.e., in the ratio mix of 0.08kg composite probiotics preparations and 1kg feeds) mouse is fed afterwards, it is continuous to see
It examines 30 days, dead and undue toxicity reaction, off-test, anatomic observation liver,kidney,spleen, stomach, the heart, lung and intestines is had no during experiment
Equal tissues are showed no abnormal change.According to acute toxicity criteria, which belongs to nontoxic grade.
(2) chronic toxicity test：Mix (quality is carried out using the composite probiotics preparations and feed of the embodiment of the present invention 1
Than being 0.02:1, i.e., in the ratio mix of 0.02kg composite probiotics preparations and 1kg feeds) mouse is fed afterwards, continuously feed 80
It, as a result shows：The mouse fur of feeding composite probiotics preparations of the present invention is smooth, and drinking-water of ingesting is normal, and behavioral activity is normal,
Blood parameters and hematology fluctuate in normal range (NR), organize internal organs no abnormality seen, generally speaking have no that toxicity reacts.
(3) Piglet feed test：Use composite probiotics preparations and the feed of the present invention 1 carry out mix (mass ratio for
0.3:100, i.e., in the ratio mix of 0.3kg composite probiotics preparations and 100kg feeds) piglet is fed afterwards, continuous feeding 40 days,
As a result it shows：Piglet well-grown, the hair color of feeding composite probiotics preparations of the present invention are smooth, Gain weight is substantially better than does not make
With the piglet of composite probiotics preparations of the present invention, the symptoms such as rare diarrhea of piglet, it is dead to there is not piglet during entire feeding
Generally speaking the phenomenon that dying has no any toxicity reaction.
Embodiment 5：The influence of oligosaccharide, tryptophan and zinc lactate for composite probiotics preparations using effect
In R＆D process of the present invention, inventor is special according to the growth characteristic of microorganism and the nutrition of piglet and growth
Point has finally determined technical scheme of the present invention through repetition test, and in comparison, which there is best technology to imitate
Fruit, can greatly promote and piglet in beneficial bacteria of intestinal tract flora growth and colony balance, improve the immunocompetence of piglet, reduce
The generation of diarrhea, in order to embody relevant technique effect, the following selected part test recipe of inventor is proved and is illustrated, tool
Body formula is referring to the following table 1：
1 embodiment 1 of table and comparative examples
| Embodiment 1 | Control 1 | Control 2 | Control 3 | Control 4 | Control 5 | |
| Bacillus licheniformis | 12 | 12 | 12 | 12 | 12 | 12 |
| Saccharomyces cerevisiae | 3 | 3 | 3 | 3 | 3 | 3 |
| Animal bifidobacteria | 25 | 25 | 25 | 25 | 25 | 25 |
| Lactobacillus acidophilus | 25 | 25 | 25 | 25 | 25 | 25 |
| Streptococcus thermophilus | 4 | 4 | 4 | 4 | 4 | 4 |
| Tryptophan | 0.0005 | 0 | 0.0005 | 0 | 0.0005 | 0.0005 |
| Xylo-oligosaccharide | 25 | 25 | 25 | 25 | 27.5 | 13 |
| Galactomannans | 2.5 | 2.5 | 2.5 | 2.5 | 0 | 13 |
| Zinc lactate | 0.00005 | 0.00005 | 0 | 0 | 0.00005 | 0.00005 |
Wherein bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus are bacterium powder
Dosage form, effectively viable bacteria content is 1.5 × 10 in Bacillus licheniformis powder preparation8CFU/g, in S. cervisiae powder preparation
Effective viable bacteria content is 1.75 × 108CFU/g, effectively viable bacteria content is 1.5 × 10 in animal bifidobacteria bacterium powder preparation9CFU/
G, effectively viable bacteria content is 6.5 × 10 in lactobacillus acidophilus bacterium powder preparation8CFU/g is effectively living in streptococcus thermophilus bacterium powder preparation
Bacterial content is 4.0 × 107CFU/g。
Screened 140 suckling pigs are equally divided into blank control group, 1 test group of embodiment, comparative examples examination
Group is tested, every group 20, every group of 4 repetitions each repeat 5, record of weighing per the disconnected navel of column piglet childbirth end and wean, experiment
Number of days is 30d.The corresponding probiotics preparation of 0.3% mass percent is added in pig starter feed used by test group, it is right
It is fed using conventional pig starter feed according to group, the equal Free nursing of piglet and feeding.
(1) influence of the probiotics preparation to piglet average daily gain and diarrhea rate
Weigh in the morning on an empty stomach when piglet just birth and wean, calculates average daily gain and the diarrhea rate of every group of piglet.Wherein
Diarrhea rate calculates：The health status of every group of swinery is observed daily, records diarrhea situation, grice diarrhoea is finally counted as unit of group
Head number (1 grice diarrhoea, 1 day note, 1 diarrhea.
Every group of diarrhea total degree/(the total head number × raising number of days of every group of pig in experimental period) of diarrhea rate (%)=in experimental period.
Influence of 2 probiotics preparation of table to piglet average daily gain and diarrhea rate
By with the test result of upper table 2 it is found that the embodiment of the present invention 1 composite probiotics preparations feed piglet, average daily
It is better than control group and blank control group, for Average weight increasing a day rate compares best control group 5, daily body weight gain in terms of weightening
Nearly 8g/d is also improved, and diarrhea rate also just corresponds to the 1/4 of control group 5, the two is compared, two kinds only in composite probiotics preparations
The adding proportion of oligosaccharide is different, this has also confirmed the conclusion (of pressure testing) of inventor, when the ratio of xylo-oligosaccharide and galactomannans
When example is 10 or so, and when xylo-oligosaccharide occupies leading position, best test effect could be obtained, and only with xylo-oligosaccharide
Or both ratio it is close when, effect is worse than the embodiment of the present invention 1.Pass through the comparison sheet of embodiment 1 and control group 1-3
It is bright, whether distinguishing the addition for essentially consisting in tryptophan and zinc lactate therebetween, based on the above experiment comparison result it is found that simple add
Tryptophan or zinc lactate cannot obtain good technique effect, only when the two is added simultaneously in use, could obtain good
Technique effect, diarrhea rate falls to the 1/5 of control group 1-3, and Average weight increasing a day improves 10g/d or more, illustrate tryptophan and
Zinc lactate has the function of synergy in composite probiotics preparations.
(2) influence of the probiotics preparation to piglet serum cytokines, intestinal mucosa SIgA
In experiment 21 days, each group detected interleukin-1 ' beta ' in 20% ratio, 4 parts of blood sampling at random using ELISA method
(IL-1 β), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α).In experiment the 30th day, 1 experiment of every group of Tu
With pig, takes about 10 centimetres of duodenums to cut, fully rinse tissue mucosa mucus with physiological saline, detected using ELISA method
Intestinal mucosa SIgA is horizontal.Specific test result is shown in Table 3：
Influence of 3 probiotics preparation of table to piglet serum cytokines, intestinal mucosa SIgA
By the above test result it is found that the use of probiotics preparation can effectively improve the immune level of piglet, and lead to
The comparison crossed between embodiment 1 and control group 1-5 shows that the composite probiotics preparations of embodiment 1 compare control group more can be effective
Raising piglet disease resistance, achieve unexpected technique effect.Embodiment 1 is white thin compared to the control group for 1-5
- 1 β of born of the same parents' interleukin (IL-1 β), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) and intestinal mucosa SIgA water
Averagely it is higher than control group, the addition of the ratio and tryptophan, zinc lactate that illustrate oligosaccharide is for the present invention with important
Meaning, the raising of the restriction of exactly this oligosaccharide adding proportion and the addition of tryptophan, zinc lactate to piglet immunological ability
Achieve unexpected technique effect.
Because of piglet digestive system, immunity function hypoplasia, it is easy to induce the symptoms such as piglet indigestion, diarrhea, currently
The morbidity and mortality of grice diarrhoea are all very high, and the composite probiotics preparations of the present invention can significantly improve the immune of piglet
Ability, improves its immune level and disease resistance, effectively avoids the generation of diarrhea, from the result of table 1 it can also be seen that this hair
Bright composite probiotics preparations significantly reduce the Incidence of Diarrhea of piglet by the immune disease-resistance ability of improvement piglet.
(3) influence of the probiotics preparation to piglet fecal microorganism
When testing the 21st day, every group each repeats to choose 1 piglet close to average weight, acquires fresh excreta sample
Product are placed in -18 DEG C of refrigerators and preserve, detection Bacillus acidi lactici, Bifidobacterium and Escherichia coli quantity.Microflora is with every gram of excrement
Logarithm (the log of contained bacterial community sum10CFU/g it) indicates.1g excrement is weighed in aseptic operating platform carries glass in 99ml
It is shaken up in the sterile saline of pearl, takes 1mL in test tube, sterile 0.9% physiological saline of 9mL is added, vibrated mixing, press successively
10 times of proportional diluteds are to 10-7.Escherichia coli culture medium is LB culture mediums, and Bacillus acidi lactici culture medium is MS culture mediums, Bifidobacterium
Culture medium is LB agar mediums, carries out coated plate and culture.
Influence of 4 probiotics preparation of table to piglet fecal microorganism
| Blank control | Embodiment 1 | Control 1 | Control 2 | Control 3 | Control 4 | Control 5 | |
| Bifidobacterium | 7.78 | 8.79 | 8.45 | 8.12 | 7.89 | 8.02 | 8.37 |
| Bacillus acidi lactici | 8.55 | 9.24 | 9.01 | 8.87 | 8.66 | 8.89 | 9.05 |
| Escherichia coli | 8.98 | 8.06 | 8.35 | 8.56 | 8.68 | 8.43 | 8.35 |
By the above test result it is found that the use of probiotics preparation can effectively improve intestine of young pigs flora, Neng Gouzeng
Add the content of the probiotics such as anaerobic bacteria Bifidobacterium and Bacillus acidi lactici, while the increasing of Escherichia coli can also be reduced to a certain extent
It grows, to play the role of adjusting intestinal flora.Embodiment 1 for 1-5, promotes Bifidobacterium and lactic acid bar compared to the control group
The effect of bacterium and inhibition Escherichia coli are higher than control group, illustrate the ratio of oligosaccharide and the addition pair of tryptophan, zinc lactate
Have great importance for the present invention, the addition of the restriction and tryptophan, zinc lactate of exactly this oligosaccharide adding proportion
Unexpected technique effect is achieved to the raising of piglet immunological ability.
Embodiment 6：Feeding examination is carried out for Zhejiang Province breeding pig farm, Fujian Province breeding pig farm and Hunan breeding pig farm
It tests, the composite probiotics preparations of 0.2% embodiment of the present invention 1 is added in pig starter feed, observe growth and the diarrhea of piglet
Situation, feedback result show that composite probiotics preparations using the present invention can improve the upgrowth situation of piglet, reduce diarrhea rate
And the death rate, piglet Gain weight are improved, and there is superior technique effect compared to commercially available all kinds of probiotics preparations.
Claims (10)
1. a kind of composite probiotics preparations, which is characterized in that the composite probiotics preparations are by bacillus licheniformis, wine brewing ferment
Mother, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate group
At.
2. composite probiotics preparations according to claim 1, which is characterized in that the composite probiotics preparations are by following heavy
Amount point at being grouped as：10-15 parts of bacillus licheniformis, 2-4 parts of saccharomyces cerevisiaes, 20-30 parts of animal bifidobacterias, 20-30 parts
Lactobacillus acidophilus, 3-5 part streptococcus thermophilus, 0.0004-0.0006 parts of tryptophans, 20-30 parts of xylo-oligosaccharides, 2-3 portions of galas are sweet
Reveal glycan and 0.00003-0.00008 parts of zinc lactate compositions.
3. composite probiotics preparations according to claim 1, which is characterized in that the composite probiotics preparations are by following heavy
Amount point at being grouped as：12 parts of bacillus licheniformis, 3 parts of saccharomyces cerevisiaes, 25 parts of animal bifidobacterias, 25 parts of lactobacillus acidophilus, 4
Part streptococcus thermophilus, 0.0005 part of tryptophan, 25 parts of xylo-oligosaccharides, 2.5 portions of galactomannans and 0.00005 part of zinc lactate group
At.
4. composite probiotics preparations according to claim 1, which is characterized in that the composite probiotics preparations are by following heavy
Amount point at being grouped as：10 parts of bacillus licheniformis, 2 parts of saccharomyces cerevisiaes, 30 parts of animal bifidobacterias, 20 parts of lactobacillus acidophilus, 3
Part streptococcus thermophilus, 0.0004 part of tryptophan, 20 parts of xylo-oligosaccharides, 2 portions of galactomannans and 0.00008 part of zinc lactate group
At.
5. composite probiotics preparations according to claim 1, which is characterized in that the composite probiotics preparations are by following heavy
Amount point at being grouped as：15 parts of bacillus licheniformis, 3 parts of saccharomyces cerevisiaes, 20 parts of animal bifidobacterias, 30 parts of lactobacillus acidophilus, 5
Part streptococcus thermophilus, 0.0006 part of tryptophan, 30 parts of xylo-oligosaccharides, 3 portions of galactomannans and 0.00003 part of zinc lactate group
At.
6. composite probiotics preparations according to any one of claims 1-5, which is characterized in that wherein lichens gemma bar
Bacterium, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus are bacterium powder dosage form, Bacillus licheniformis
Effective viable bacteria content is 1.0 × 10 in powder preparation8CFU/g-2.0×108CFU/g, effectively viable bacteria contains in S. cervisiae powder preparation
Amount is 1.5 × 108CFU/g-2.0×108CFU/g, in animal bifidobacteria bacterium powder preparation effectively viable bacteria content be 1.0 ×
109CFU/g-2.0×109CFU/g, effectively viable bacteria content is 5.0 × 10 in lactobacillus acidophilus bacterium powder preparation8CFU/g-8.0×
108CFU/g, effectively viable bacteria content is 3.0 × 10 in streptococcus thermophilus bacterium powder preparation7CFU/g-5.0×107CFU/g。
7. composite probiotics preparations according to claim 6, which is characterized in that wherein bacillus licheniformis, saccharomyces cerevisiae,
Animal bifidobacteria, lactobacillus acidophilus, streptococcus thermophilus are bacterium powder dosage form, in Bacillus licheniformis powder preparation effectively
Viable bacteria content is 1.5 × 108CFU/g, effectively viable bacteria content is 1.75 × 10 in S. cervisiae powder preparation8CFU/g, animal are double
Effective viable bacteria content is 1.5 × 10 in discrimination bacillus bacterium powder preparation9CFU/g, effective viable bacteria content in lactobacillus acidophilus bacterium powder preparation
It is 6.5 × 108CFU/g, effectively viable bacteria content is 4.0 × 10 in streptococcus thermophilus bacterium powder preparation7CFU/g。
8. the preparation method of the composite probiotics preparations according to any one of claim 1-7, which is characterized in that the system
Preparation Method includes the following steps：Step 1 weighs bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, acidophilus by weight
Lactobacillus and streptococcus thermophilus bacterium powder, tryptophan, xylo-oligosaccharide, galactomannans and zinc lactate；Step 2, by what is weighed
Bacillus licheniformis, saccharomyces cerevisiae, animal bifidobacteria, lactobacillus acidophilus and streptococcus thermophilus bacterium powder, tryptophan, oligomeric wood
Sugar, galactomannans and zinc lactate are uniformly mixed, and are then dispensed, are placed at 4 DEG C and preserve.
9. application of the composite probiotics preparations in pig starter feed described in claim 1-7 any one, which is characterized in that described
Additive amount of the composite probiotics preparations in pig starter feed is 0.2-0.4% (mass percent).
10. a kind of pig starter feed, which is characterized in that be added with the power of 0.2-0.4% mass percentages in the pig starter feed
Profit requires any one of 1-7 composite probiotics preparations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810186361.8A CN108402320A (en) | 2018-03-07 | 2018-03-07 | A kind of composite probiotics preparations and its application in pig starter feed |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810186361.8A CN108402320A (en) | 2018-03-07 | 2018-03-07 | A kind of composite probiotics preparations and its application in pig starter feed |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108402320A true CN108402320A (en) | 2018-08-17 |
Family
ID=63130384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810186361.8A Pending CN108402320A (en) | 2018-03-07 | 2018-03-07 | A kind of composite probiotics preparations and its application in pig starter feed |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108402320A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109329566A (en) * | 2018-12-05 | 2019-02-15 | 湖南赛福资源饲料科技有限公司 | For improving the premixed feed and preparation method of piglet gastrointestinal health |
| CN110226671A (en) * | 2019-07-19 | 2019-09-13 | 广东省农业科学院农业生物基因研究中心 | A kind of piglet full price fermented feed and its production method |
| CN112042832A (en) * | 2020-09-28 | 2020-12-08 | 井冈山大学 | Poultry breeding microbial feed additive and preparation method and application thereof |
| CN112586617A (en) * | 2020-12-08 | 2021-04-02 | 中国科学院亚热带农业生态研究所 | Composite microecological preparation and application thereof in preparation of feed for improving meat quality of Bama miniature pigs |
| CN112617001A (en) * | 2020-12-05 | 2021-04-09 | 九江礼涞生物科技有限公司 | Preparation method of animal intestinal probiotics for feed and application of product |
| CN114698730A (en) * | 2022-04-24 | 2022-07-05 | 长沙绿叶生物科技有限公司 | Compound bacterium preparation for sow midwifery and preparation method and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496822A (en) * | 2009-02-18 | 2009-08-05 | 上海谱莱生物技术有限公司 | Composite probiotics micro-ecological formulation and preparation method |
| WO2013007742A1 (en) * | 2011-07-12 | 2013-01-17 | Nestec S.A. | Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs |
| CN104397396A (en) * | 2014-11-12 | 2015-03-11 | 广德裕农野生豪猪繁育基地 | Porcupine feed containing microorganisms |
| CN104472887A (en) * | 2014-12-29 | 2015-04-01 | 邳州市小河科技发展有限公司 | Probiotic feed additive |
| CN104799120A (en) * | 2015-05-18 | 2015-07-29 | 何兴江 | Feed additive for improving low-temperature stress resistance of chicken |
| CN106509457A (en) * | 2016-11-08 | 2017-03-22 | 河南普尼尔生物制药有限公司 | Intestinal tract health protection agent capable of reducing stress of weanling pigs as well as preparation method and use method thereof |
-
2018
- 2018-03-07 CN CN201810186361.8A patent/CN108402320A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496822A (en) * | 2009-02-18 | 2009-08-05 | 上海谱莱生物技术有限公司 | Composite probiotics micro-ecological formulation and preparation method |
| WO2013007742A1 (en) * | 2011-07-12 | 2013-01-17 | Nestec S.A. | Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs |
| CN104397396A (en) * | 2014-11-12 | 2015-03-11 | 广德裕农野生豪猪繁育基地 | Porcupine feed containing microorganisms |
| CN104472887A (en) * | 2014-12-29 | 2015-04-01 | 邳州市小河科技发展有限公司 | Probiotic feed additive |
| CN104799120A (en) * | 2015-05-18 | 2015-07-29 | 何兴江 | Feed additive for improving low-temperature stress resistance of chicken |
| CN106509457A (en) * | 2016-11-08 | 2017-03-22 | 河南普尼尔生物制药有限公司 | Intestinal tract health protection agent capable of reducing stress of weanling pigs as well as preparation method and use method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 章晋武: ""决明子多糖的结构及其对仔猪生长、免疫和肠道微生态的影响研究"", 《中国优秀博硕士学位论文全文数据库（硕士） 医药卫生科技辑》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109329566A (en) * | 2018-12-05 | 2019-02-15 | 湖南赛福资源饲料科技有限公司 | For improving the premixed feed and preparation method of piglet gastrointestinal health |
| CN110226671A (en) * | 2019-07-19 | 2019-09-13 | 广东省农业科学院农业生物基因研究中心 | A kind of piglet full price fermented feed and its production method |
| CN112042832A (en) * | 2020-09-28 | 2020-12-08 | 井冈山大学 | Poultry breeding microbial feed additive and preparation method and application thereof |
| CN112617001A (en) * | 2020-12-05 | 2021-04-09 | 九江礼涞生物科技有限公司 | Preparation method of animal intestinal probiotics for feed and application of product |
| CN112586617A (en) * | 2020-12-08 | 2021-04-02 | 中国科学院亚热带农业生态研究所 | Composite microecological preparation and application thereof in preparation of feed for improving meat quality of Bama miniature pigs |
| CN112586617B (en) * | 2020-12-08 | 2023-03-10 | 中国科学院亚热带农业生态研究所 | Composite microecological preparation and application thereof in preparation of feed for improving meat quality of Bama miniature pigs |
| CN114698730A (en) * | 2022-04-24 | 2022-07-05 | 长沙绿叶生物科技有限公司 | Compound bacterium preparation for sow midwifery and preparation method and application thereof |
| CN114698730B (en) * | 2022-04-24 | 2023-10-03 | 长沙绿叶生物科技有限公司 | Composite bacterial preparation for sow midwifery and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3609513B1 (en) | Yeast and bacterial probiotics combinations and methods of use to improve swine production | |
| CN108402320A (en) | A kind of composite probiotics preparations and its application in pig starter feed | |
| CN102326677B (en) | Composite micro-ecological feed additive and preparation method and premix thereof | |
| CN104758318B (en) | A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate | |
| US11607434B2 (en) | Bacillus compositions and methods of use with ruminants | |
| Geary et al. | Effect on weaner pig performance and diet microbiology of feeding a liquid diet acidified to pH 4 with either lactic acid or through fermentation with Pediococcus acidilactici | |
| KR102255611B1 (en) | Method for preparing fermented total mixed ration using microbial strain complex | |
| CN103907749A (en) | Biological fermentation active carrier type composite premix feed as well as preparation method and application thereof | |
| CN104206789B (en) | It is a kind of to be used to prevent mastitis for milk cows and the feed addictive of brucellosis and preparation method thereof | |
| CN109805183A (en) | With the probiotics of glucose oxidase compatibility and its preparation method and application | |
| CN110313551B (en) | Wet solid state fermentation soybean meal product and preparation method and application thereof | |
| CN102885202A (en) | Novel poultry micro-ecological preparation and preparation method thereof | |
| CN108967742A (en) | A kind of compound micro-ecological preparation used for aquiculture and feed | |
| CN107821789A (en) | A kind of biologic ferment for improving fishes and shrimps intestinal health degree and its preparation method and application | |
| CN110326708A (en) | A kind of functionality additive package and its application | |
| CN107772195A (en) | One kind poultry poultry fodder takes off mould dose and preparation method thereof | |
| CN102461733A (en) | Composition containing xylo-oligosaccharide | |
| JP4199685B2 (en) | New lactic acid bacteria | |
| KR101893735B1 (en) | Pharmaceutical copositions for animal of previntion of intestinal disorder the same method | |
| KR20150117184A (en) | Composition of formulated diets comprising novel lactic acid bacteria, fungus and bacterium | |
| CN108850606A (en) | A kind of feed addictive and the preparation method and application thereof for improving piglet immunological function and improving intestinal microflora | |
| CN101684449A (en) | Fodder premix and special bacterial strain thereof | |
| Satık | Effects of kefir as a probiotic source on the performance and health of young dairy calves | |
| CN112514995A (en) | Suckling pig immune milk powder rich in probiotics and prebiotics and preparation method thereof | |
| CN114424800B (en) | Feed additive for improving intestinal health index of broiler chickens and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180817 |